IL320213A - ליפידים ניתנים ליוניזציה - Google Patents

ליפידים ניתנים ליוניזציה

Info

Publication number
IL320213A
IL320213A IL320213A IL32021325A IL320213A IL 320213 A IL320213 A IL 320213A IL 320213 A IL320213 A IL 320213A IL 32021325 A IL32021325 A IL 32021325A IL 320213 A IL320213 A IL 320213A
Authority
IL
Israel
Prior art keywords
ionizable lipids
ionizable
lipids
Prior art date
Application number
IL320213A
Other languages
English (en)
Inventor
Sabah Kasmi
Coen Ruben De
Koker Stefaan De
Shrinivas Dumbre
Original Assignee
Etherna Immunotherapies Nv
Sabah Kasmi
Coen Ruben De
Koker Stefaan De
Shrinivas Dumbre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Etherna Immunotherapies Nv, Sabah Kasmi, Coen Ruben De, Koker Stefaan De, Shrinivas Dumbre filed Critical Etherna Immunotherapies Nv
Publication of IL320213A publication Critical patent/IL320213A/he

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A61K48/0033Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being non-polymeric
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/5123Organic compounds, e.g. fats, sugars
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/68One oxygen atom attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL320213A 2022-10-21 2023-10-20 ליפידים ניתנים ליוניזציה IL320213A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22202996 2022-10-21
PCT/EP2023/079320 WO2024084056A1 (en) 2022-10-21 2023-10-20 Ionizable lipids

Publications (1)

Publication Number Publication Date
IL320213A true IL320213A (he) 2025-06-01

Family

ID=83902867

Family Applications (1)

Application Number Title Priority Date Filing Date
IL320213A IL320213A (he) 2022-10-21 2023-10-20 ליפידים ניתנים ליוניזציה

Country Status (7)

Country Link
EP (1) EP4605375A1 (he)
JP (1) JP2026512620A (he)
KR (1) KR20250091282A (he)
CN (1) CN120303251A (he)
AU (1) AU2023362573A1 (he)
IL (1) IL320213A (he)
WO (1) WO2024084056A1 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202541786A (zh) 2023-12-22 2025-11-01 比利時商eTheRNA免疫治療公司 脂質奈米顆粒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2341311A1 (fr) * 1976-02-20 1977-09-16 Parcor Derives de la pyridoxine
JP2717481B2 (ja) * 1992-08-25 1998-02-18 富士写真フイルム株式会社 ハロゲン化銀カラー写真感光材料
ATE481385T1 (de) * 2000-05-31 2010-10-15 Santen Pharmaceutical Co Ltd (pyridinyl)alkyl-amide oder -harnstoffe als tnf- alpha bildung inhibitoren
IL157397A (en) * 2003-08-14 2013-03-24 Dpharm Ltd Compounds, pharmaceutical compositions comprising same and uses thereof for the preparation of a medicament for the treatment of epilepsy
WO2012069605A1 (en) * 2010-11-26 2012-05-31 Dr. August Wolff Gmbh & Co. Kg Arzneimittel Novel e,e-diene compounds and their use as medicaments and cosmetics
MX2019010837A (es) * 2017-03-14 2019-12-19 Polyactiva Pty Ltd Conjugado biodegradable de farmaco-polimero.
IL303659A (he) 2020-12-23 2023-08-01 Etherna Immunotherapies Nv שומנים מייננים
WO2022207938A1 (en) * 2021-04-02 2022-10-06 Universiteit Gent Ionizable lipids and lipid nanoparticles comprising said ionizable lipids for delivery of therapeutic agents

Also Published As

Publication number Publication date
CN120303251A (zh) 2025-07-11
KR20250091282A (ko) 2025-06-20
JP2026512620A (ja) 2026-04-20
WO2024084056A1 (en) 2024-04-25
EP4605375A1 (en) 2025-08-27
AU2023362573A1 (en) 2025-05-29

Similar Documents

Publication Publication Date Title
EP4199934A4 (en) FUNCTIONAL IONIZABLE PHOSPHOLIPIDES
SG11202102921WA (en) Ionizable amine lipids
CA216403S (en) Hoodie
EP4347577A4 (en) KC2-TYPE LIPIDS
IL325587A (he) ליפידים הניתנים ליינון
IL325487A (he) ליפידים הניתנים ליינון
IL315356A (he) ליפידים בעלי יכולת ינון וקומפוזיציות המכילות אותם
CA236863S (en) Vitamin
IL318544A (he) ליפידים קטיוניים הניתנים ליינון המשלבים סיליקון
CA214906S (en) Multi-cooker
IL320213A (he) ליפידים ניתנים ליוניזציה
IL292335B1 (he) ליפידים של פוליאתילן גליקול
IL320210A (he) לפידים יוניים חדשים
CA3297138A1 (en) Ionizable lipids
CA3271221A1 (en) Ionizable lipids
EP4419148A4 (en) IONIZABLE CATIONIC COMPOUND
CA3270349A1 (en) Novel ionizable lipids
HK40103657A (en) Ionizable lipids for nanomaterials
HK40096029A (en) Functional ionizable phospholipids
CA220099S (en) An electrosprayer
CA3286597A1 (en) Ionizable anionic lipids
HK40104510A (en) Nanomaterials comprising an ionizable lipid
GB2619010B (en) An electrical fitting
HK40054140A (en) Ionizable amine lipids
CA215379S (en) E-track